Target intelligence / Profile preview

Brain-derived neurotrophic factor–mammalian target of rapamycin pathway (BDNF–mTOR pathway)

Target
BDNF–mTOR pathway
Molecular classification
Other (signaling pathway)
01

Overview

The "BDNF/mTOR pathway" refers to a cellular signaling cascade rather than a single molecular target. It describes the interaction between brain-derived neurotrophic factor (BDNF)—a neurotrophin essential for neuronal survival, growth, and synaptic plasticity—and the mammalian target of rapamycin (mTOR) kinase complex. Upon binding to its high-affinity receptor TrkB on neurons, BDNF activates several intracellular pathways including PI3K/Akt, which in turn activates mTOR[2][4][5]. The mTOR complex then regulates protein synthesis by phosphorylating downstream effectors such as 4E-BP1 and p70S6 kinase[1][3]. This coordinated activity is crucial for processes like dendritic branching, local protein translation in neurons, synaptic plasticity, learning and memory formation[2][3][5]. Alterations or dysregulation of this pathway are implicated in various diseases including neurodegenerative disorders (such as Alzheimer’s disease), psychiatric conditions (like depression), multiple sclerosis, and certain cancers where aberrant growth factor signaling leads to uncontrolled cell proliferation[4][5][8]. However, "BDNF/mTOR pathway" is not itself a discrete therapeutic target but rather a description of interconnected molecular events involving two distinct proteins—BDNF (a ligand) and mTOR (a serine/threonine kinase). Each component can be considered an individual therapeutic target; drugs may act on TrkB receptors or directly inhibit/activate mTOR. Therefore: The entry "BDNF/mTOR pathway" is not a canonical name for any single molecule or receptor but denotes an important biological process involving multiple targets. If structured information about specific drug interactions or biomarkers is needed for either BDNF/TrkB or mTOR individually—as opposed to the combined “pathway”—those should be queried separately.

Other names
BDNF/mTOR signaling axisBDNF–TrkB–mTOR pathwaybrain-derived neurotrophic factor and mTOR signaling cascade
02

Biological functions

Signal transductionProtein synthesis regulationNeuronal growth and differentiationSynaptic plasticity
03

Disease associations

Neurodegenerative diseaseCancer

Beyond the preview

Go deeper on Brain-derived neurotrophic factor–mammalian target of rapamycin pathway (BDNF–mTOR pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brain-derived neurotrophic factor–mammalian target of rapamycin pathway (BDNF–mTOR pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call